Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Raw Materials: 2024

  • Whitehawk Therapeutics' Raw Materials was N/A to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is N/A change from last year.
  • Whitehawk Therapeutics' Raw Materials amounted to $3.5 million in Q4 2024.
  • Over the past 5 years, Whitehawk Therapeutics' Raw Materials peaked at $3.5 million during Q4 2024, and registered a low of $3.5 million during Q4 2024.
  • For the 1-year period, Whitehawk Therapeutics' Raw Materials averaged around $3.5 million, with its median value being $3.5 million (2024).